- $3.77bn
- $4.09bn
- $2.72bn
NYSE ORDER IMBALANCE 55033.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-Altice USA, C4 Therapeutics, Lincoln National
Brief: Envista Reports Third Quarter 2022 Earnings
Envista Holdings Corp reports results for the quarter ended in September - Earnings Summary
NYSE ORDER IMBALANCE 391953.0 SHARES ON SELL SIDE
Envista Holdings Corp expected to post earnings of 47cents a share - Earnings Preview
NYSE ORDER IMBALANCE 65421.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 58929.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 57166.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 293672.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 63074.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 68629.0 SHARES ON BUY SIDE
Beware spins from Danaher’s well-oiled M&A machine
NYSE ORDER IMBALANCE 163747.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 266303.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 63289.0 SHARES ON SELL SIDE
U.S. STOCKS ON THE MOVE-Envista, Bed Bath & Beyond, United Parcel Service
Envista Holdings climbs as Piper Sandler upgrades, raises PT
U.S. RESEARCH ROUNDUP-Envista Holdings, Shockwave Medical, Vivid Seats